A Phase II Study of Methotrexate, Etoposide, Dexamethasone and Pegaspargase Sandwiched with Radiotherapy in the Treatment of Newly Diagnosed, Stage IE to IIE Extranodal Natural-Killer/T-Cell Lymphoma, Nasal-Type

BACKGROUND: A phase II study of methotrexate, etoposide, dexamethasone, and pegaspargase (MESA) sandwiched with radiotherapy for newly diagnosed, stage IE-IIE extranodal natural-killer/T-cell lymphoma, nasal-type (ENKTL) was conducted to explore its clinical efficacy and safety, as well as novel ser...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Peng-Peng, Xiong, Jie, Cheng, Shu, Zhao, Xia, Wang, Chao-Fu, Cai, Gang, Zhong, Hui-Juan, Huang, Heng-Ye, Chen, Jia-Yi, Zhao, Wei-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704067/
https://www.ncbi.nlm.nih.gov/pubmed/29056540
http://dx.doi.org/10.1016/j.ebiom.2017.10.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5704067/
https://www.ncbi.nlm.nih.gov/pubmed/29056540
http://dx.doi.org/10.1016/j.ebiom.2017.10.011

Ejemplares similares